Headline
The latest stories from AHA Today.
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-19 vaccine.
In this first episode of a four-part series with the Association for Healthcare Philanthropy, Alice Ayres, president and CEO of the AHP, discusses how philanthropy is no longer just an add-on but a strategic driver for hospitals and health systems.
Susan Doherty, AHA’s vice president of field engagement, and Rebecca Chickey, AHA’s senior director of behavioral health services, write on the unique ways suicide affects rural communities and the innovative methods rural health care providers are using to care for their neighbors.
The AHA expressed support Sept. 22 to House and Senate sponsors of the Medicare Advantage Prompt Pay Act (H.R. 5454/S. 2879), legislation that would apply a federal prompt payment standard to MA plans to help ensure that health care providers receive timely payments from MA plans for necessary…
President Trump Sept. 19 signed a proclamation increasing the fee to $100,000 for new H-1B petitions filed by employers, as well as implementing other restrictions on entry of certain nonimmigrant workers. The restrictions began on Sept. 21 and expire, absent extension, after 12 months.
The Centers for Disease Control and Prevention Sept. 18 issued a health advisory on a new outbreak of Ebola in the Democratic Republic of the Congo.
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly for contract year 2026.
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote that would have funded the government through Nov. 21. The CR was passed by the House earlier in the day.
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID.
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules to laboratory-developed tests. The final rule is in response to a March 31 federal district court decision that also vacated the FDA’s 2024 final rule.